Elanco Animal Health Net Total Equity Issued/Repurchased 2016-2024 | ELAN

Elanco Animal Health net total equity issued/repurchased from 2016 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
Elanco Animal Health Annual Net Total Equity Issued/Repurchased
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $1,220
2019 $N/A
2018 $1,660
2017 $N/A
2016 $N/A
2015 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.840B $4.439B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.866B 19.58
Encompass Health (EHC) United States $11.757B 24.92
DaVita (DVA) United States $10.848B 14.40
Chemed (CHE) United States $8.419B 26.46
Option Care Health (OPCH) United States $5.395B 24.05
RadNet (RDNT) United States $4.004B 84.73
Amedisys (AMED) United States $3.151B 21.19
LifeStance Health (LFST) United States $2.644B 0.00
Addus HomeCare (ADUS) United States $1.932B 22.10
Astrana Health (ASTH) United States $1.822B 36.51
U.S Physical Therapy (USPH) United States $1.099B 28.03
Aveanna Healthcare Holdings (AVAH) United States $0.944B 0.00
Pennant (PNTG) United States $0.927B 37.07
Atai Life Sciences (ATAI) Germany $0.300B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00